Walgreens Boots Alliance, Inc.

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, ONC has a market cap of 34.3B. Regarding current trading prices, WBA is priced at $12.04, while ONC trades at $309.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas ONC's P/E ratio is -190.15. In terms of profitability, WBA's ROE is -0.70%, compared to ONC's ROE of -0.05%. Regarding short-term risk, WBA is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check ONC's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, INSM has a market cap of 27B. Regarding current trading prices, WBA is priced at $12.04, while INSM trades at $127.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas INSM's P/E ratio is -22.58. In terms of profitability, WBA's ROE is -0.70%, compared to INSM's ROE of -1.95%. Regarding short-term risk, WBA is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check INSM's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, HROWM has a market cap of 1.4B. Regarding current trading prices, WBA is priced at $12.04, while HROWM trades at $26.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas HROWM's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to HROWM's ROE of -0.18%. Regarding short-term risk, WBA is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.Check HROWM's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, WBA is priced at $12.04, while HROWL trades at $25.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas HROWL's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to HROWL's ROE of -0.18%. Regarding short-term risk, WBA is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.Check HROWL's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, ATNFW has a market cap of 1.1B. Regarding current trading prices, WBA is priced at $12.04, while ATNFW trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas ATNFW's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to ATNFW's ROE of -1.41%. Regarding short-term risk, WBA is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check ATNFW's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, WBA is priced at $12.04, while LFMDP trades at $23.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas LFMDP's P/E ratio is -10.53. In terms of profitability, WBA's ROE is -0.70%, compared to LFMDP's ROE of +1.55%. Regarding short-term risk, WBA is less volatile compared to LFMDP. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check LFMDP's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, LFMD has a market cap of 304.9M. Regarding current trading prices, WBA is priced at $12.04, while LFMD trades at $6.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas LFMD's P/E ratio is -32.15. In terms of profitability, WBA's ROE is -0.70%, compared to LFMD's ROE of +1.55%. Regarding short-term risk, WBA is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check LFMD's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, HITI has a market cap of 215.6M. Regarding current trading prices, WBA is priced at $12.04, while HITI trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas HITI's P/E ratio is -29.56. In terms of profitability, WBA's ROE is -0.70%, compared to HITI's ROE of -0.07%. Regarding short-term risk, WBA is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check HITI's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, PETS has a market cap of 61.1M. Regarding current trading prices, WBA is priced at $12.04, while PETS trades at $3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas PETS's P/E ratio is 296.00. In terms of profitability, WBA's ROE is -0.70%, compared to PETS's ROE of +0.00%. Regarding short-term risk, WBA is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check PETS's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, YI has a market cap of 58.2M. Regarding current trading prices, WBA is priced at $12.04, while YI trades at $6.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas YI's P/E ratio is -3.11. In terms of profitability, WBA's ROE is -0.70%, compared to YI's ROE of +0.11%. Regarding short-term risk, WBA is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check YI's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, WBA is priced at $12.04, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas RAD's P/E ratio is -0.05. In terms of profitability, WBA's ROE is -0.70%, compared to RAD's ROE of +2.76%. Regarding short-term risk, WBA is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check RAD's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, RNTX has a market cap of 27.5M. Regarding current trading prices, WBA is priced at $12.04, while RNTX trades at $1.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas RNTX's P/E ratio is -0.41. In terms of profitability, WBA's ROE is -0.70%, compared to RNTX's ROE of -1.12%. Regarding short-term risk, WBA is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check RNTX's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, NEUP has a market cap of 15.2M. Regarding current trading prices, WBA is priced at $12.04, while NEUP trades at $8.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas NEUP's P/E ratio is 0.43. In terms of profitability, WBA's ROE is -0.70%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, WBA is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check NEUP's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, WBA is priced at $12.04, while MEDS trades at $7.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas MEDS's P/E ratio is -0.31. In terms of profitability, WBA's ROE is -0.70%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, WBA is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check MEDS's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, WBA is priced at $12.04, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas CJJD's P/E ratio is -0.46. In terms of profitability, WBA's ROE is -0.70%, compared to CJJD's ROE of -0.20%. Regarding short-term risk, WBA is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check CJJD's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, WBA is priced at $12.04, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas SSY's P/E ratio is -2.86. In terms of profitability, WBA's ROE is -0.70%, compared to SSY's ROE of +0.12%. Regarding short-term risk, WBA is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check SSY's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, WBA is priced at $12.04, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas MDVL's P/E ratio is -0.05. In terms of profitability, WBA's ROE is -0.70%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, WBA is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check MDVL's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, LFLY has a market cap of 771.5K. Regarding current trading prices, WBA is priced at $12.04, while LFLY trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas LFLY's P/E ratio is -0.14. In terms of profitability, WBA's ROE is -0.70%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, WBA is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.Check LFLY's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, LFLYW has a market cap of 292.4K. Regarding current trading prices, WBA is priced at $12.04, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas LFLYW's P/E ratio is -0.04. In terms of profitability, WBA's ROE is -0.70%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, WBA is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.Check LFLYW's competition here

WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WBA stands at 10.4B. In comparison, BIMI has a market cap of 1.2K. Regarding current trading prices, WBA is priced at $12.04, while BIMI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WBA currently has a P/E ratio of -1.64, whereas BIMI's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to BIMI's ROE of -2.94%. Regarding short-term risk, WBA is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.Check BIMI's competition here